-
EP1638956
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP1638956
| EP1638956 - 2,3-SUBSTITUTED 5,6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATORS [Right-click to bookmark this link] | Status | The application is deemed to be withdrawn Status updated on 19.03.2010 Database last updated on 09.09.2024 | Most recent event Tooltip | 19.03.2010 | Application deemed to be withdrawn | published on 21.04.2010 [2010/16] | Applicant(s) | For all designated states AstraZeneca AB 151 85 Södertälje / SE | [2006/13] | Inventor(s) | 01 /
CHENG, Leifeng AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | 02 /
WILSTERMANN, Michael AstraZeneca R & D Mölndal S-431 83 Mölndal / SE | [2006/13] | Representative(s) | Wahlström, Christer AstraZeneca Global Intellectual Property 151 85 Södertälje / SE | [N/P] |
| Former [2006/13] | Wahlström, Stig Christer Gunnar AstraZeneca Global Intellectual Property S-151 85 Södertälje / SE | Application number, filing date | 04749010.7 | 16.06.2004 | [2006/13] | WO2004SE00968 | Priority number, date | GB20030014261 | 19.06.2003 Original published format: GB 0314261 | [2006/13] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2004111039 | Date: | 23.12.2004 | Language: | EN | [2004/52] | Type: | A1 Application with search report | No.: | EP1638956 | Date: | 29.03.2006 | Language: | EN | The application published by WIPO in one of the EPO official languages on 23.12.2004 takes the place of the publication of the European patent application. | [2006/13] | Search report(s) | International search report - published on: | SE | 23.12.2004 | Classification | IPC: | C07D401/14 | [2006/13] | CPC: |
C07D241/24 (EP,US);
A61P1/04 (EP);
A61P11/00 (EP);
A61P15/00 (EP);
A61P25/00 (EP);
A61P25/08 (EP);
A61P25/14 (EP);
A61P25/16 (EP);
A61P25/18 (EP);
A61P25/22 (EP);
A61P25/24 (EP);
A61P25/28 (EP);
A61P25/30 (EP);
A61P3/04 (EP);
A61P3/06 (EP);
A61P31/00 (EP);
A61P37/00 (EP);
A61P37/02 (EP);
A61P5/00 (EP);
A61P9/00 (EP);
A61P9/02 (EP);
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IT, LI, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR [2006/13] | Extension states | AL | Not yet paid | HR | Not yet paid | LT | Not yet paid | LV | Not yet paid | MK | Not yet paid | Title | German: | 2,3-SUBSTITUIERTE 5,6-DIARYL-PYRAZINDERIVATIVE ALS CB1-MODULATOREN | [2006/13] | English: | 2,3-SUBSTITUTED 5,6-DIARYL-PYRAZINE DERIVATIVES AS CB1 MODULATORS | [2006/13] | French: | UTILISATION DE DERIVES DE 5,6-DIARYL-PYRAZINE 2,3-SUBSTITUEE COMME MODULATEURS DU RECEPTEUR CANNABINOIDE 1 | [2006/13] | Entry into regional phase | 19.01.2006 | National basic fee paid | 19.01.2006 | Designation fee(s) paid | 19.01.2006 | Examination fee paid | Examination procedure | 19.01.2006 | Examination requested [2006/13] | 23.10.2006 | Despatch of a communication from the examining division (Time limit: M06) | 09.07.2007 | Reply to a communication from the examining division | 10.09.2007 | Despatch of a communication from the examining division (Time limit: M04) | 13.12.2007 | Reply to a communication from the examining division | 19.02.2008 | Despatch of a communication from the examining division (Time limit: M04) | 18.06.2008 | Reply to a communication from the examining division | 19.06.2009 | Communication of intention to grant the patent | 30.10.2009 | Application deemed to be withdrawn, date of legal effect [2010/16] | 03.12.2009 | Despatch of communication that the application is deemed to be withdrawn, reason: fee for grant / fee for printing not paid in time [2010/16] | Request for further processing for: | 09.07.2007 | Request for further processing filed | 09.07.2007 | Full payment received (date of receipt of payment) Request granted | 20.07.2007 | Decision despatched | Fees paid | Renewal fee | 30.06.2006 | Renewal fee patent year 03 | 02.07.2007 | Renewal fee patent year 04 | 28.03.2008 | Renewal fee patent year 05 | Penalty fee | Additional fee for renewal fee | 30.06.2009 | 06 M06 Not yet paid |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [XP]WO03051851 (ASTRAZENECA AB [SE], et al); | [XP]WO03051850 (ASTRAZENECA AB [SE], et al); | [X]WO9202513 (FUJISAWA PHARMACEUTICAL CO [JP]); | [A]WO0170700 (SOLVAY PHARM BV [NL]); | [A]EP0656354 (SANOFI SA [FR]) | [X] - OHTA A. ET AL., "Anti-platelet aggregation activity of some pyrazines", BIOL. PHARM. BULL., (1997), vol. 20, no. 10, pages 1076 - 1081, XP001118289 |